Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Zuckerman

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
JACC. Cardiovascular Interventions|February 25, 2012
Live case demonstration of interventional cardiology procedures: a regulatory perspectiveAndrew Farb, Bram Zuckerman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 25, 2007
FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devicesJennifer Goode, Wolf Sapirstein, Bram Zuckerman
Circulation|February 13, 2008
Regulatory perspective on embolic protection device approval for saphenous vein graft stenting with a single-arm trial using risk-adjusted prediction modelRobert P Fiorentino, Bram Zuckerman, Takahiro Uchida
Blood Pressure Monitoring|July 6, 2017
Automated noninvasive blood pressure monitors: a Food and Drug Administration review perspectiveBradley Quinn, Shawn Forrest, Matthew Hillebrenner, et al.
Journal of the American College of Cardiology|January 11, 2011
VARC consensus report: the FDA perspectiveMatthew G Hillebrenner, Julie A Swain, Bram Zuckerman
European Heart Journal|January 11, 2011
VARC consensus report: the FDA perspectiveMatthew G Hillebrenner, Julie A Swain, Bram Zuckerman
Expert Review of Medical Devices|February 7, 2007
US FDA perspective on regulatory issues affecting circulatory assist devicesWolf Sapirstein, Eric Chen, Julie Swain, et al.
Journal of Vascular Surgery|November 10, 2009
FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemiaAllison Kumar, Steven S Brooks, Kenneth Cavanaugh, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 18, 2005
A US Food and Drug Administration perspective on cardiac resynchronization and ventricular assist device trialsOwen Faris, Eric Chen, Michael Berman, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 24, 2010
Interventional cardiology live case presentations: regulatory considerationsAndrew Farb, Sheila A Brown, Deborah A Wolf, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
JACC. Cardiovascular Interventions|February 25, 2012
Live case demonstration of interventional cardiology procedures: a regulatory perspectiveAndrew Farb, Bram Zuckerman
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 25, 2007
FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devicesJennifer Goode, Wolf Sapirstein, Bram Zuckerman
Circulation|February 13, 2008
Regulatory perspective on embolic protection device approval for saphenous vein graft stenting with a single-arm trial using risk-adjusted prediction modelRobert P Fiorentino, Bram Zuckerman, Takahiro Uchida
Blood Pressure Monitoring|July 6, 2017
Automated noninvasive blood pressure monitors: a Food and Drug Administration review perspectiveBradley Quinn, Shawn Forrest, Matthew Hillebrenner, et al.
Journal of the American College of Cardiology|January 11, 2011
VARC consensus report: the FDA perspectiveMatthew G Hillebrenner, Julie A Swain, Bram Zuckerman
European Heart Journal|January 11, 2011
VARC consensus report: the FDA perspectiveMatthew G Hillebrenner, Julie A Swain, Bram Zuckerman
Expert Review of Medical Devices|February 7, 2007
US FDA perspective on regulatory issues affecting circulatory assist devicesWolf Sapirstein, Eric Chen, Julie Swain, et al.
Journal of Vascular Surgery|November 10, 2009
FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemiaAllison Kumar, Steven S Brooks, Kenneth Cavanaugh, et al.
Congestive Heart Failure (Greenwich, Conn.)|August 18, 2005
A US Food and Drug Administration perspective on cardiac resynchronization and ventricular assist device trialsOwen Faris, Eric Chen, Michael Berman, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 24, 2010
Interventional cardiology live case presentations: regulatory considerationsAndrew Farb, Sheila A Brown, Deborah A Wolf, et al.
Pageof 4